Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry.

Patricia Juliao,Keele Wurst,Jeanne M Pimenta,Kim Gemzoe,Helain Landy, M Anthony Moody,Hugh Tilson,Deborah Covington, Tammy Moore,Rebecca Marino, Jennifer Gilbride,Andrew Liu,Paige Meizlik,Michelle Petri

Birth defects research（2023）

引用 3|浏览6

暂无评分

摘要

Low recruitment numbers for the BPR and incomplete information limit the conclusions regarding belimumab exposure during pregnancy. There was no pattern or common mechanism of birth defects associated with belimumab within the BPR data.

查看译文

关键词

belimumab,major birth defects,pregnancy,systemic lupus erythematosus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要